Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > Articles by: Ryan McArthur
data.ansm: an online platform to find out more about adverse drug reactions and product shortages
2023 April Apr 24

data.ansm: an online platform to find out more about adverse drug reactions and product shortages

https://ansm.sante.fr/actualites/data-ansm-une-plateforme-en-ligne-pour-en-savoir-plus-sur-les-effets-indesirables-des-medicaments-et-les-ruptures-de-stock

Read more
Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 11-14 April 2023
2023 April Apr 21

Meeting Highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) meeting 11-14 April 2023

Read more
Comittee for Medicinal Products for Human use : Minutes for the meeting on 23-26 January 2023
2023 April Apr 17

Comittee for Medicinal Products for Human use : Minutes for the meeting on 23-26 January 2023

Read more
EMA: Minutes of PRAC meeting on 28 Nov to 01 Dec 2022
2023 April Apr 14

EMA: Minutes of PRAC meeting on 28 Nov to 01 Dec 2022

Read more
How to limit the occurrence of adverse effects of mydriatic eye drops in children?
2023 April Apr 11

How to limit the occurrence of adverse effects of mydriatic eye drops in children?

https://ansm.sante.fr/actualites/comment-limiter-la-survenue-des-effets-indesirables-des-collyres-mydriatiques-chez-les-enfants?fbclid=IwAR0-r9IYprxvpZnb_cCXk249sawSqKCIWoxEv00kpqRWuMrMcqro7VGhg-s

Read more
2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2023 April Apr 07

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

Read more
About us – EMA
2023 April Apr 03

About us – EMA

Read more
Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM
2023 March Mar 30

Pharmacovigilance – Questions and answers – Access to medicines not authorised in France for the treatment of serious diseases – ANSM

Read more
2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
2023 March Mar 27

2022 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

Read more
WHO Pharmaceuticals Newsletter
2023 March Mar 23

WHO Pharmaceuticals Newsletter

Read more
  • « Previous
  • Next »

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes of PRAC meeting on 13 – 16 January 2025
  • CTIS newsflash – 25 March 2025
  • 2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
Copyright © 2018 - Pharmya - Legal terms - Quality Policy